Cargando…

Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine

Type 1 Diabetes Mellitus (T1DM) is a common hyperglycemic disease characterized by the autoimmune destruction of insulin-producing beta cells of the pancreas. Various attempts have been made to understand the complex interplay of genetic and environmental factors which lead to the development of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Popoviciu, Mihaela Simona, Kaka, Nirja, Sethi, Yashendra, Patel, Neil, Chopra, Hitesh, Cavalu, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056161/
https://www.ncbi.nlm.nih.gov/pubmed/36983604
http://dx.doi.org/10.3390/jpm13030422
_version_ 1785016057484804096
author Popoviciu, Mihaela Simona
Kaka, Nirja
Sethi, Yashendra
Patel, Neil
Chopra, Hitesh
Cavalu, Simona
author_facet Popoviciu, Mihaela Simona
Kaka, Nirja
Sethi, Yashendra
Patel, Neil
Chopra, Hitesh
Cavalu, Simona
author_sort Popoviciu, Mihaela Simona
collection PubMed
description Type 1 Diabetes Mellitus (T1DM) is a common hyperglycemic disease characterized by the autoimmune destruction of insulin-producing beta cells of the pancreas. Various attempts have been made to understand the complex interplay of genetic and environmental factors which lead to the development of the autoimmune response in an individual. T1DM is frequently associated with other autoimmune illnesses, the most common being autoimmune thyroid disorders affecting more than 90% of people with T1D and autoimmune disorders. Antithyroid antibodies are present in around 20% of children with T1D at the start of the illness and are more frequent in girls. Patients with T1DM often have various other co-existing multi-system autoimmune disorders including but not limited to thyroid diseases, parathyroid diseases, celiac disease, vitiligo, gastritis, skin diseases, and rheumatic diseases. It is a consistent observation in clinics that T1DM patients have other autoimmune disorders which in turn affect their prognosis. Concomitant autoimmune illness might affect diabetes care and manifest itself clinically in a variety of ways. A thorough understanding of the complex pathogenesis of this modern-day epidemic and its association with other autoimmune disorders has been attempted in this review in order to delineate the measures to prevent the development of these conditions and limit the morbidity of the afflicted individuals as well. The measures including antibody screening in susceptible individuals, early identification and management of other autoimmune disorders, and adoption of personalized medicine can significantly enhance the quality of life of these patients. Personalized medicine has recently gained favor in the scientific, medical, and public domains, and is frequently heralded as the future paradigm of healthcare delivery. With the evolution of the ‘omics’, the individualization of therapy is not only closer to reality but also the need of the hour.
format Online
Article
Text
id pubmed-10056161
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100561612023-03-30 Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine Popoviciu, Mihaela Simona Kaka, Nirja Sethi, Yashendra Patel, Neil Chopra, Hitesh Cavalu, Simona J Pers Med Review Type 1 Diabetes Mellitus (T1DM) is a common hyperglycemic disease characterized by the autoimmune destruction of insulin-producing beta cells of the pancreas. Various attempts have been made to understand the complex interplay of genetic and environmental factors which lead to the development of the autoimmune response in an individual. T1DM is frequently associated with other autoimmune illnesses, the most common being autoimmune thyroid disorders affecting more than 90% of people with T1D and autoimmune disorders. Antithyroid antibodies are present in around 20% of children with T1D at the start of the illness and are more frequent in girls. Patients with T1DM often have various other co-existing multi-system autoimmune disorders including but not limited to thyroid diseases, parathyroid diseases, celiac disease, vitiligo, gastritis, skin diseases, and rheumatic diseases. It is a consistent observation in clinics that T1DM patients have other autoimmune disorders which in turn affect their prognosis. Concomitant autoimmune illness might affect diabetes care and manifest itself clinically in a variety of ways. A thorough understanding of the complex pathogenesis of this modern-day epidemic and its association with other autoimmune disorders has been attempted in this review in order to delineate the measures to prevent the development of these conditions and limit the morbidity of the afflicted individuals as well. The measures including antibody screening in susceptible individuals, early identification and management of other autoimmune disorders, and adoption of personalized medicine can significantly enhance the quality of life of these patients. Personalized medicine has recently gained favor in the scientific, medical, and public domains, and is frequently heralded as the future paradigm of healthcare delivery. With the evolution of the ‘omics’, the individualization of therapy is not only closer to reality but also the need of the hour. MDPI 2023-02-26 /pmc/articles/PMC10056161/ /pubmed/36983604 http://dx.doi.org/10.3390/jpm13030422 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Popoviciu, Mihaela Simona
Kaka, Nirja
Sethi, Yashendra
Patel, Neil
Chopra, Hitesh
Cavalu, Simona
Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
title Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
title_full Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
title_fullStr Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
title_full_unstemmed Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
title_short Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
title_sort type 1 diabetes mellitus and autoimmune diseases: a critical review of the association and the application of personalized medicine
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056161/
https://www.ncbi.nlm.nih.gov/pubmed/36983604
http://dx.doi.org/10.3390/jpm13030422
work_keys_str_mv AT popoviciumihaelasimona type1diabetesmellitusandautoimmunediseasesacriticalreviewoftheassociationandtheapplicationofpersonalizedmedicine
AT kakanirja type1diabetesmellitusandautoimmunediseasesacriticalreviewoftheassociationandtheapplicationofpersonalizedmedicine
AT sethiyashendra type1diabetesmellitusandautoimmunediseasesacriticalreviewoftheassociationandtheapplicationofpersonalizedmedicine
AT patelneil type1diabetesmellitusandautoimmunediseasesacriticalreviewoftheassociationandtheapplicationofpersonalizedmedicine
AT choprahitesh type1diabetesmellitusandautoimmunediseasesacriticalreviewoftheassociationandtheapplicationofpersonalizedmedicine
AT cavalusimona type1diabetesmellitusandautoimmunediseasesacriticalreviewoftheassociationandtheapplicationofpersonalizedmedicine